Stevanato Group Announces Change in Ex-Dividend Date for its Dividend
07 Giugno 2023 - 6:30PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that it has changed the previously announced
ex-dividend date of June 5, 2023 for its cash dividend of EUR 0.054
per share, payable on July 17, 2023, to comply with New York Stock
Exchange rules. The new ex-dividend date for the dividend will be
June 7, 2023, and the record date remains June 6, 2023. The
dividend will continue to be payable on July 17, 2023.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230607005751/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Grafico Azioni Stevanato (NYSE:STVN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Stevanato (NYSE:STVN)
Storico
Da Giu 2023 a Giu 2024